Drugs / NTCELL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02683629 | Feb 2016 → Oct 2017 | Parkinson disease | Living Cell Technologies | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTCELL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02683629 ↗ |
| Modality | Cell therapy | “NTCELL comprises neonatal porcine choroid plexus cells encapsulated in alginate microcapsules.” NCT02683629 ↗ |
| Route | Other | “Intracranial choroid plexus cell transplantation” NCT02683629 ↗ |